We Are Eagle Pharmaceuticals, Inc.
Progressing Treatments With Innovative Formulations
We strive to develop products that benefit both patients and healthcare professionals (HCPs).
The reference injectable brands that are the primary focus of the Eagle portfolio have an estimated value of $3.4 billion.1
Research and Development
Eagle Pharmaceuticals is developing product formulations in several therapeutic areas including oncology, critical care, and orphan diseases.
Eagle Pharmaceuticals is committed to developing optimized formulations that could improve safety and efficiency for patients and healthcare professionals.